기술별(PCR 기반, 유전자 시퀀싱 기반, 하이브리디제이션 기반, 마이크로어레이 기반), 응용 분야별(감염성 질환, 종양학, 혈액학, 산전 검사, 내분비학 및 기타), 검사 장소별(OTC 및 POC), 최종 사용별(분산형 실험실, 병원, 재택 치료, 보조 생활 의료 시설 및 기타), 지역별(북미, 유럽, 아시아 태평양, 라틴 아메리카, 중동 및 아프리카), 분석 및 예측 2022~2032년.

2032년까지 글로벌 진료 시점 분자 진단 시장 규모는  118억 4천만 달러에 이를 것으로 전망됩니다.

Spherical Insights & Consulting에서 발표한 연구 보고서에 따르면, 글로벌 진료 시점 분자 진단 시장 규모는 2022년 71억 3천만 달러에서 2032년 118억 4천만 달러로 성장할 것으로 예상되며, 예측 기간 동안 연평균 성장률(CAGR)은 5.2%가 될 것으로 전망됩니다.

" 글로벌 현장 진료 분자 진단 시장 규모, 점유율 및 COVID-19 영향 분석, 기술별(PCR 기반, 유전자 시퀀싱 기반, 하이브리드화 기반 및 마이크로어레이  기반), 응용 분야별(감염성 질환, 종양학, 혈액학, 산전 검사, 내분비학 및 기타), 검사 장소별(OTC 및 POC), 최종 용도별(분산형 실험실, 병원, 재택 치료, 보조 생활 의료 시설 및 기타), 지역별( 북미 , 유럽, 아시아 태평양, 라틴 아메리카, 중동 및 아프리카), 분석 및 예측 2022-2032" 보고서에서 150개의 시장 데이터 표, 수치 및  차트가 포함된 200페이지 분량의 주요 산업 통찰력을 살펴보세요.

Point-of-care molecular diagnostics (POC MDx) is an emerging field that enables rapid and precise detection of diseases and genetic conditions at the point of patient care. Utilizing nucleic acid amplification techniques, such as PCR and isothermal amplification, POC MDx allows for on-site testing without the need for specialized laboratories. The technology provides timely results, facilitating immediate clinical decision-making, especially in remote or resource-limited settings. POC MDx has the potential to transform healthcare delivery by improving patient outcomes through early detection and targeted treatments, making it a promising tool for disease management and prevention on a global scale.

The POC segment is expected to grow at a CAGR of around 5.3% during the forecast period

Based on the test location, the global point-of-care molecular diagnostics market is segmented into OTC and POC. The point-of-care test location segment is projected to experience the fastest growth during the forecast period due to several key factors. Point-of-care tests (POCTs) offer the advantage of conducting rapid diagnostic tests directly at the patient's bedside or in community settings, without the need for complex laboratory infrastructure. The increasing demand for immediate results, especially in emergency situations or remote areas, drives the adoption of POCTs. Moreover, advancements in technology have led to the development of portable and user-friendly POCT devices, further promoting their use in decentralized healthcare settings. These factors contribute to the rapid expansion of the point-of-care test location segment in the molecular diagnostics market.

The decentralized labs segment held the largest market share with more than 41.6% in 2022.

Based on the end-use, the global point-of-care molecular diagnostics market is segmented into decentralized labs, hospitals, home care, assisted living healthcare facilities, and others. The dominance of the decentralized labs segment in the molecular diagnostics market can be attributed to several factors. Decentralized labs, such as clinics, point-of-care facilities, and ambulatory care centers, offer the advantage of rapid and on-site testing, eliminating the need for sample transportation to centralized laboratories. This convenience enables timely diagnosis and faster clinical decision-making, especially in critical situations. Additionally, the increasing adoption of point-of-care molecular diagnostics in resource-limited or remote areas further bolsters the segment's growth. The decentralized labs' ability to provide accessible and efficient testing solutions has made them a preferred choice, contributing to their largest revenue share in the market.

Asia-Pacific is predicted to grow at a fastest CAGR of around 5.4% over the projected period

Based on region, Asia Pacific is projected to register the fastest compound annual growth within the forecast period in the point-of-care molecular diagnostics market due to several key factors. The region's large and growing population, coupled with an increasing prevalence of infectious diseases and chronic conditions, creates a substantial demand for rapid and accurate diagnostic solutions. Additionally, improvements in healthcare infrastructure, rising healthcare expenditure, and growing awareness about the benefits of early disease detection further drive market growth. Moreover, advancements in technology, increasing investments in research and development, and the entry of major market players into the region contribute to the projected rapid expansion of the point-of-care molecular diagnostics market in Asia Pacific.

Some of the major players in the global point-of-care molecular diagnostics market include Abbott, Bayer AG, F. Hoffmann-La Roche AG, Nova Biomedical, QIAGEN, Nipro Diagnostics, Danaher, Bio-Rad Laboratories, Inc., bioMerieux, Agilent Technologies, Inc., Abaxis, and OraSure Technologies.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global point-of-care molecular diagnostics market based on the below-mentioned segments:

Point-of-Care Molecular Diagnostics Market, By Technology

• PCR-based
• Genetic Sequencing-based
• Hybridization-based
• Microarray-based

Point-of-Care Molecular Diagnostics Market, By Application

• Infectious Diseases
• Oncology
• Hematology
• Prenatal Testing
• Endocrinology
• Others

Point-of-Care Molecular Diagnostics Market, By Test Location

• OTC
• POC

Point-of-Care Molecular Diagnostics Market, By End-Use

• Decentralized Labs
• Hospitals
• Home-care
• Assisted Living Healthcare Facilities
• Others

Point-of-Care Molecular Diagnostics Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

이메일:  inquiry@sphericalinsights.com ,  sales@sphericalinsights.com

문의하기:  https://www.sphericalinsights.com/contact-us

팔로우하세요:  LinkedIn  |  Facebook  |  Twitter